Your browser doesn't support javascript.
loading
Residual pulmonary infiltrates, symptoms and diffusion impairment at 1-year after severe COVID-19 infection have different associated factors.
Menéndez, Rosario; Méndez, Raúl; Latorre, Ana; González-Jiménez, Paula; Peces-Barba, Germán; Molina, María; España, Pedro Pablo; García, Estela; Consuegra-Vanegas, Angélica; Pando-Sandoval, Ana; Panadero, Carolina; Figueira-Gonçalves, Juan Marco; De la Rosa, David; Sibila, Oriol; Martínez-Pitarch, María Dolores; Toledo, Nuria; Cejudo, Pilar; Almonte-Batista, Wanda; Macías-Paredes, Abigail; Badenes, Diana; Pérez-Rodas, Eli Nancy; Lázaro, Javier; Quirós, Sarai; Cordovilla, Rosa; Cano-Pumarega, Irene; Torres, Antoni.
Afiliación
  • Menéndez R; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Méndez R; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain.
  • Latorre A; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • González-Jiménez P; The University of Valencia, Valencia, Spain.
  • Peces-Barba G; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Molina M; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain.
  • España PP; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
  • García E; The University of Valencia, Valencia, Spain.
  • Consuegra-Vanegas A; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Pando-Sandoval A; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain.
  • Panadero C; Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Figueira-Gonçalves JM; Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain.
  • De la Rosa D; The University of Valencia, Valencia, Spain.
  • Sibila O; Hospital Fundación Jiménez Díaz, Madrid, Spain.
  • Martínez-Pitarch MD; Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain.
  • Toledo N; Hospital de Galdakao-Usansolo, Galdakao, Spain.
  • Cejudo P; Hospital de Cabueñes, Gijón, Spain.
  • Almonte-Batista W; Hospital Universitario de A Coruña, A Coruña, Spain.
  • Macías-Paredes A; Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Badenes D; Hospital de Getafe, Getafe, Spain.
  • Pérez-Rodas EN; Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
  • Lázaro J; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Quirós S; Hospital Clínic, Barcelona, Spain.
  • Cordovilla R; Hospital Lluís Alcanyís, Játiva, Spain.
  • Cano-Pumarega I; Hospital Son Espases, Palma, Spain.
  • Torres A; Hospital Virgen del Rocío, Sevilla, Spain.
J Intern Med ; 294(1): 69-82, 2023 07.
Article en En | MEDLINE | ID: mdl-37038609
INTRODUCTION: After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, patients may show lung sequelae on radiology and functional impairment at the 1-year follow-up. We aimed to describe the persistence of symptoms, radiological alterations, or reduced diffusing capacity of the lung for carbon monoxide (DLCO ) at 1-year follow-up in patients from the Spanish Registry RECOVID. METHODS: RECOVID collected symptom and radiological and functional lung tests data on hospitalized patients with coronavirus disease 2019 during the acute phase and at the 6- and 12-month follow-up visits. RESULTS: Of the 2500 enrolled survivors (90% admitted to the ward), 1874 had follow-up visits for up to a year. Of these, 42% continued to present with symptoms, 27% had radiological sequelae and 31% had reduced DLCO . Independently associated factors included female sex, asthma and the requirement for invasive or non-invasive mechanical ventilation. Complete radiological resolution was 72.2% at 12 months; associated factors with incomplete recovery were age, male sex, oxygen or respiratory support, corticosteroids and an initial SpO2 /FiO2 <450 or CURB-65 ≥2. Reduced DLCO was observed in 31% of patients at 12 months; associated factors were older age, female sex, smoking habit, SpO2 /FiO2 <450 and CURB-65 ≥2 and the requirement of respiratory support.At 12 months, a proportion of the asymptomatic patients showed reduced DLCO (9.5%), radiological findings (25%) or both (11%). CONCLUSIONS: The factors associated with symptom persistence, incomplete radiological resolution and DLCO <80% differed according to age, sex, comorbidities and respiratory support. The burden of symptoms, reduced DLCO and incomplete radiological resolution were considerable in patients with SARS-CoV-2 pneumonia at the 1-year follow-up after hospitalisation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido